Search results
George Goldsmith. Chairman and Co-founder. George is an entrepreneur dedicated to bringing about positive change in society with particular focus on health and wellbeing. George’s early training and experience was a multi-disciplinary blending of cognitive psychology, clinical psychology and computer science.
Oct 23, 2020 · George Goldsmith, the CEO of Compass Pathways — the first psilocybin company to trade publicly in the US — insists that he's not in the psychedelics business.
George Goldsmith, CEO and Co-founder at COMPASS Pathways, talks about the positive results of our phase IIb trial of COMP360 psilocybin therapy for treatment-resistant depression. ...more.
Dec 4, 2020 · George Goldsmith Talks About His Drug for Treating Depression The Compass Pathways CEO and his physician wife researched the psychoactive ingredient in “magic mushrooms” while seeking to help...
Learn how George Goldsmith built a $360 million business by accelerating patient access to innovation in mental health. He shares his journey from technology to psychology, his vision for 2030, and his advice for founders and leaders.
Mar 28, 2024 · “When we started Compass eight years ago, we could not have imagined how the company would grow and mature,” said George Goldsmith, outgoing board chair of Compass Pathways. “The company is on a strong, positive trajectory to develop psilocybin treatment under Kabir Nath’s principled leadership.
Oct 25, 2022 · George Goldsmith, the co-founder and executive chairman of Compass, said the company’s patent strategy was necessary to ensure that psilocybin therapy would one day be available to people...
